Relationship of the lytic state to successful reperfusion with standard- and low-dose intracoronary streptokinase.
- 28 February 1985
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 71 (3), 562-570
- https://doi.org/10.1161/01.cir.71.3.562
Abstract
The influence of a systemic lytic state on reperfusion obtained after intracoronary streptokinase (SK) therapy has been evaluated in 15 patients with acute myocardial infarction and complete coronary occlusion. Coronary angiographic studies and measurements of blood fibrinolytic parameters were repeated at 15 min intervals during the infusion of a standard dose of SK and were compared with the results with approximately one-tenth the standard dose. Successful reperfusion was obtained in only 20% (2/10) of patients receiving the low dose, compared with a 75% to 80% success rate in patients receiving the standard dose as initial treatment (4/5) or as follow-up treatment of patients in whom low-dose therapy failed (6/8). There was a striking association between reperfusion and development of the lytic state in that all 12 treatments resulting in reperfusion also caused a lytic state and all seven treatments that failed to produce a lytic state also failed to induce reperfusion (p less than .001). Among the successfully treated patients, the dose of SK that induced a lytic state was relatively constant. However, coronary arterial thrombi differed in susceptibility to treatment. Sensitive thrombi (5/12) dissolved before the lytic state occurred and at a lower SK dose than that needed to cause a lytic state; more resistant thrombi (7/12) required a longer time and a significantly larger SK dose to dissolve. These results indicate that intrinsic properties of the thrombus influence the rate and outcome of treatment and that a minimal dose of SK (about 200,000 U) is required to ensure lasting reperfusion in susceptible patients.(ABSTRACT TRUNCATED AT 250 WORDS)This publication has 20 references indexed in Scilit:
- Effective and fibrin-specific clot lysis by a zymogen precursor form of urokinase (pro-urokinase). A study in vitro and in two animal species.Journal of Clinical Investigation, 1984
- Coronary thrombolysis by intravenous streptokinase in acute myocardial infarction: Acute and follow-up studiesThe American Journal of Cardiology, 1984
- Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial InfarctionNew England Journal of Medicine, 1983
- Functional improvement of jeopardized myocardium following intracoronary streptokinase infusion in acute myocardial infarction.Journal of Clinical Investigation, 1983
- A Randomized Trial of Intracoronary Streptokinase in the Treatment of Acute Myocardial InfarctionNew England Journal of Medicine, 1983
- Intracoronary Fibrinolytic Therapy in Acute Myocardial InfarctionNew England Journal of Medicine, 1983
- Myocardial Salvage after Intracoronary Thrombolysis with Streptokinase in Acute Myocardial InfarctionNew England Journal of Medicine, 1981
- Fibrinolysis with acyl-enzymes: a new approach to thrombolytic therapyNature, 1981
- Intracoronary thrombolysis in evolving myocardial infarctionAmerican Heart Journal, 1981
- Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial InfarctionNew England Journal of Medicine, 1980